Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma ; volume:12 ; number:1 ; day:9 ; month:4 ; year:2024 ; pages:1-19 ; date:12.2024
Cancer & metabolism ; 12, Heft 1 (9.4.2024), 1-19, 12.2024

Klassifikation
Medizin, Gesundheit

Urheber
Peterson, Erik R.
Sajjakulnukit, Peter
Scott, Andrew J.
Heaslip, Caleb
Andren, Anthony
Wilder-Romans, Kari
Zhou, Weihua
Palavalasa, Sravya
Korimerla, Navyateja
Lin, Angelica
O’Brien, Alexandra
Kothari, Ayesha
Zhao, Zitong
Zhang, Li
Morgan, Meredith A.
Venneti, Sriram
Koschmann, Carl
Jabado, Nada
Lyssiotis, Costas A.
Castro, Maria G.
Wahl, Daniel R.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s40170-024-00341-7
URN
urn:nbn:de:101:1-2406241138554.494343295395
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:48 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Peterson, Erik R.
  • Sajjakulnukit, Peter
  • Scott, Andrew J.
  • Heaslip, Caleb
  • Andren, Anthony
  • Wilder-Romans, Kari
  • Zhou, Weihua
  • Palavalasa, Sravya
  • Korimerla, Navyateja
  • Lin, Angelica
  • O’Brien, Alexandra
  • Kothari, Ayesha
  • Zhao, Zitong
  • Zhang, Li
  • Morgan, Meredith A.
  • Venneti, Sriram
  • Koschmann, Carl
  • Jabado, Nada
  • Lyssiotis, Costas A.
  • Castro, Maria G.
  • Wahl, Daniel R.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Prognostic factors analysis of diffuse midline glioma

Prognostic factors analysis of diffuse midline glioma

Correction to: Prognostic factors analysis of diffuse midline glioma

Correction to: Prognostic factors analysis of diffuse midline glioma

Specific Combination Therapy for H3K27M Pediatric Diffuse Midline Glioma

Specific Combination Therapy for H3K27M Pediatric Diffuse Midline Glioma

A H3K27M-targeted vaccine in adults with diffuse midline glioma

A H3K27M-targeted vaccine in adults with diffuse midline glioma

MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered

MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered

Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma

Infusion-related side-effects during convection enhanced delivery for brainstem-diffuse midline glioma/diffuse intrinsic pontine glioma

Flank Pain as a First Symptom of a Diffuse Midline Glioma

Flank Pain as a First Symptom of a Diffuse Midline Glioma

A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis

A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant

Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma

Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma

Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma

Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma

Single-cell RNA sequencing of anaplastic ependymoma and H3K27M-mutant diffuse midline glioma

Single-cell RNA sequencing of anaplastic ependymoma and H3K27M-mutant diffuse midline glioma

Verbundene Objekte